Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Cancer Res. 2013 Apr 10;73(11):3336–3346. doi: 10.1158/0008-5472.CAN-12-3292

Table 1.

Sensitivity of leukaemic cell lines to PFI-1

Cell line Cell type GI50[μM]
MV4;11 childhood B-cell myelomonocytic acute leukaemia (MLL/AF4) 1.5 ± 1
THP-1 acute monocytic leukaemia (MLL/AF9) 4 ± 2
KASUMI-1 acute myeloid leukaemia with t(8;21) translocation (AML1-ETO) 0.8 ± 1
NALM-17 Pre B-blast ALL 8 ± 4
TOM-1 Ph1-positive acute lymphoblastic leukaemia (ALL) 3 ± 5
REH adult acute lymphoblastic leukaemia (ALL) 9 ± 4
SD-1 Epstein-Barr virus immortalised Ph-1 positive ALL 8 ± 3
NALM-6 pre-B acute lymphoblastic leukaemia (t(5; 12)(q33; p13)) 8 ± 3
NOMO-1 acute monocytic leukaemia (MLL/AF9) 3 ± 3
SEMKH2 acute monocytic leukaemia (MLL/AF9) 2 ± 2
RS4;11 acute monocytic leukaemia (MLL/AF4) 2 ± 2
KOCL-45 acute monocytic leukaemia (MLL/AF4) 10 ± 5
U937 leukaemic monocytic lymphoma 5 ± 3
PL21 acute promyelolytic leukaemia 10 ± 5
SUPB-15 Ph+ childhood B-cell ALL 11 ± 4
K-562 erythroleukaemia CML blast (Bcr-ABL) >20